Neoadjuvant chemotherapy in locally advanced colon cancer. A phase II trial

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Acta oncologica

• Publication date

  2015-04-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/0284186X.2015.1037007PMID 25920359
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BRAFV600E Mutation and Its Association with Clinicopathological Features of Colorectal Cancer: A Systematic Review and Meta-Analysis

  2014cited by this paper
• Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis: the New EPOC randomised controlled trial.

  2014cited by this paper
• Selection of colon cancer patients for neoadjuvant chemotherapy by preoperative CT scan

  2014cited by this paper
• BRAF Mutations in Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis

  2014cited by this paper
• Chemotherapy-induced neuropathy and its association with quality of life among 2- to 11-year colorectal cancer survivors: results from the population-based PROFILES registry.

  2013cited by this paper
• Preliminary outcome of a treatment strategy based on perioperative chemotherapy and surgery in patients with locally advanced colon cancer

  2013cited by this paper
• Bevacizumab in stage II-III colon cancer: 5-year update of the National Surgical Adjuvant Breast and Bowel Project C-08 trial.

  2013cited by this paper
• ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making.

  2012influential reference
• Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trial

  2012cited by this paper
• Cerebral hemorrhage, warfarin, and intravenous tPA: the real risk is not treating.

  2012cited by this paper
• Explaining the unexplainable: EGFR antibodies in colorectal cancer.

  2012cited by this paper
• Accuracy of radiological staging in identifying high‐risk colon cancer patients suitable for neoadjuvant chemotherapy: a multicentre experience

  2012cited by this paper
• Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial.

  2012cited by this paper
• Quantitative Cell-Free DNA, KRAS, and BRAF Mutations in Plasma from Patients with Metastatic Colorectal Cancer during Treatment with Cetuximab and Irinotecan

  2012cited by this paper
• Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses.

  2011cited by this paper
• Adjuvant chemotherapy for stage II colon cancer with poor prognostic features.

  2011cited by this paper
• Accuracy of multidetector computed tomography in identifying poor prognostic factors in colonic cancer

  2010cited by this paper
• Diagnostic precision of CT in local staging of colon cancers: a meta-analysis.

  2010influential reference
• PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies.

  2009cited by this paper
• Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.

  2009cited by this paper
• Standardized surgery for colonic cancer: complete mesocolic excision and central ligation – technical notes and outcome

  2009cited by this paper
• Adjuvant therapy for completely resected stage II colon cancer.

  2008cited by this paper
• Preoperative computed tomography staging of nonmetastatic colon cancer predicts outcome: implications for clinical trials

  2007cited by this paper
• American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.

  2004cited by this paper
• Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

  2004cited by this paper
• Optimal two-stage designs for phase II clinical trials.

  1989cited by this paper

• Preoperative chemotherapy for colon cancer and short-term outcomes—a nationwide cohort study

  2026cites this paper
• Neoadjuvant Chemotherapy vs Upfront Surgery in Patients With Locally Advanced Colon Cancer: A Randomized Clinical Trial.

  2026cites this paper
• CT Staging of Colon Cancer: Reproducibility and Pathology Association in a Multicenter Study.

  2026cites this paper
• Mapping the landscape of locally advanced colon cancer research: a 30-year bibliometric perspective

  2025cites this paper
• Cancro del colon occluso

  2025cites this paper
• Impact of hospital volume on survival in patients with locally advanced colon cancer – A Dutch population‐based study

  2025cites this paper
• Cáncer de colon en oclusión

  2025cites this paper
• Neoadjuvant Therapy for Patients with Advanced Colon Cancer: Analysis of the National Cancer Database (NCDB)

  2025cites this paper
• Neoadjuvant chemotherapy with FOLFOXIRI for high-risk relapsed locally advanced colon cancer: a single-arm phase II trial

  2025influential citation
• Narrative review of neoadjuvant therapy in patients with locally advanced colon cancer

  2024cites this paper
• Long-term effects of neoadjuvant chemotherapy in variant histology locally advanced colon cancer: a propensity score-matched analysis

  2024cites this paper
• Neoadjuvant chemotherapy in locally advanced colon cancer: A systematic review with proportional meta-analysis.

  2024cites this paper
• Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for initially unresectable locally advanced colon cancer: short-term outcomes of an open-label, single-centre, randomised, controlled, phase 3 trial

  2024cites this paper
• Diagnostic Performance of MRI and FDG PET/CT for Preoperative Locoregional Staging of Colon Cancer: Systematic Review and Meta-Analysis.

  2024cites this paper
• Curative Surgery After Neoadjuvant Chemotherapy for Locally Advanced Sigmoid Colon Cancer With Extensive Abdominal Wall Invasion: A Case Report

  2024cites this paper
• Neoadjuvant Chemotherapy in Colon Cancer: More Than Just an Optical Illusion.

  2024cites this paper
• Evolving Standards of Care in the Management of Localized Colorectal Cancer.

  2024cites this paper
• Neoadjuvant Chemotherapy With Oxaliplatin and Fluoropyrimidine Versus Upfront Surgery for Locally Advanced Colon Cancer: The Randomized, Phase III OPTICAL Trial

  2024cites this paper
• Neoadjuvant Chemotherapy in Patients With T4b or Obstructive Colon Cancer: A Single Center Retrospective Cohort Study

  2024cites this paper
• Survival and safety after neoadjuvant chemotherapy or upfront surgery for locally advanced colon cancer: meta-analysis

  2024cites this paper
• The ELECLA trial: A multicentre randomised control trial on outcomes of neoadjuvant treatment on locally advanced colon cancer

  2024cites this paper
• Prognostic impact of extramural venous invasion detected by contrast-enhanced CT colonography in colon cancer

  2024cites this paper
• Diagnostic accuracy of CT for local staging of colon cancer: A nationwide study in the Netherlands.

  2023cites this paper
• Nationwide practice in CT-based preoperative staging of colon cancer and concordance with definitive pathology.

  2023cites this paper
• Radiologic T staging of colon cancer: renewed interest for clinical practice

  2023cites this paper
• Current Controversies in the Management of Locally Advanced Colon Cancer

  2023cites this paper
• Lymph Node Staging by CT Texture Analysis in Patients with Sigmoid Cancer

  2023cites this paper
• Neoadjuvant immunotherapy for colorectal cancer: Right regimens, right patients, right directions?

  2023cites this paper
• Pathological response and safety of FOLFOXIRI for neoadjuvant treatment of high-risk relapsed locally advanced colon cancer: study protocol for a single-arm, open-label phase II trial

  2023cites this paper
• Diagnostic Accuracy of Abdominal CT for Locally Advanced Colon Tumors: Can We Really Entrust Certain Decisions to the Reliability of CT?

  2023cites this paper
• Low adenylate kinase 5 expression is predictive of poor prognosis and promotes tumour growth by regulating the cell‐cycle pathway

  2022cites this paper
• Laparoscopic Colectomy: A Risk Factor for Postoperative Peritoneal Metastasis.

  2022cites this paper
• CT and 3 Tesla MRI in the TN Staging of Colon Cancer: A Prospective, Blind Study

  2022cites this paper
• Neoadjuvant chemotherapy in patients undergoing colonic resection for locally advanced nonmetastatic colon cancer: A nationwide propensity score matched cohort study

  2022influential citation
• Ongoing and evolving clinical trials enhancing future colorectal cancer treatment strategies

  2022cites this paper
• Comprehensive Review of Biomarkers for the Treatment of Locally Advanced Colon Cancer

  2022cites this paper
• Efficacy and Safety of Neoadjuvant Chemotherapy Combined with Adjuvant Chemotherapy for Locally Advanced Colon Cancer: A Propensity Score-Matching Analysis

  2022cites this paper
• The role of neoadjuvant chemotherapy in patients with locally advanced colon cancer: A systematic review and meta-analysis

  2022cites this paper
• Estimation of colon cancer grade and metastatic lymph node involvement using DWI/ADC sequences

  2022cites this paper
• Accurate staging of non-metastatic colon cancer with CT: the importance of training and practice for experienced radiologists and analysis of incorrectly staged cases

  2022cites this paper
• Identifying high-risk colon cancer on CT an a radiomics signature improve radiologist’s performance for T staging?

  2022cites this paper
• Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review and meta-analysis

  2021cites this paper
• Identification of Novel Transcriptome Signature as a Potential Prognostic Biomarker for Anti-Angiogenic Therapy in Glioblastoma Multiforme

  2021cites this paper
• Does neoadjuvant FOLFOX chemotherapy improve the prognosis of high‐risk Stage II and III colon cancers? Three years' follow‐up results of the PRODIGE 22 phase II randomized multicentre trial

  2021influential citation
• Neoadjuvant chemoradiotherapy for patients with unresectable radically locally advanced colon cancer: a potential improvement to overall survival and decrease to multivisceral resection

  2021cites this paper
• The Role of Neoadjuvant Chemotherapy in Locally Advanced Colon Cancer

  2021influential citation
• Stage III colon cancer: is neoadjuvant chemotherapy ready for prime time?—A narrative review of neoadjuvant chemotherapy for colon cancer

  2021cites this paper
• Management of Colorectal Cancer Patients During The COVID-19 Pandemic: Triage and Treatment

  2021cites this paper
• Neoadjuvant chemoradiotherapy in patients with unresectable locally advanced sigmoid colon cancer: clinical feasibility and outcome

  2021cites this paper
• Does preoperative neoadjuvant chemotherapy impact short-term surgical outcomes in patients with locally advanced colon cancer?

  2021influential citation
• Interventions and Outcomes for Neoadjuvant Treatment of T4 Colon Cancer: A Scoping Review

  2021influential citation
• Critical reappraisal of neoadjuvant concurrent chemoradiotherapy for treatment of locally advanced colon cancer

  2021cites this paper
• Predictors of undergoing multivisceral resection, margin status and survival in Dutch patients with locally advanced colorectal cancer.

  2021cites this paper
• L’angiocoloscanner 3D avant colectomie pour cancer : un nouvel outil pour le chirurgien

  2021cites this paper
• Computed Tomography Colonography Angiography (CTC-A) prior to colectomy for cancer: A new tool for surgeons.

  2021cites this paper
• Management of obstructive colon cancer: Current status, obstacles, and future directions

  2021cites this paper
• CMAR_A_262870 2567..2579

  2021influential citation
• Perioperative FOLFOX 4 Versus FOLFOX 4 Plus Cetuximab Versus Immediate Surgery for High-Risk Stage II and III Colon Cancers: A Phase II Multicenter Randomized Controlled Trial (PRODIGE 22).

  2020cites this paper
• How should colorectal surgeons practice during the COVID‐19 epidemic? A retrospective single‐centre analysis based on real‐world data from China

  2020cites this paper
• Continuous-Wave THz Imaging for Biomedical Samples

  2020cites this paper
• Complete Pathologic Response After Neoadjuvant Chemotherapy in Locally Advanced Colon Cancer

  2020cites this paper
• Respuesta patológica completa tras quimioterapia neoadyuvante en cáncer de colon localmente avanzado

  2020cites this paper
• Neoadjuvant Chemotherapy for Colon Cancer

  2020cites this paper
• Current management and controversies in management of T4 cancers of the colon—a narrative review of the literature

  2020cites this paper
• Neoadjuvant Chemotherapy without Radiation in Colorectal Cancer

  2020cites this paper
• A Prospective, Single-arm, Multicenter Trial of Diverting Stoma Followed by Neoadjuvant Chemotherapy Using mFOLFOX6 for Obstructive Colon Cancer

  2020cites this paper
• Neoadjuvant therapy in locally advanced colon cancer: a meta-analysis and systematic review.

  2020cites this paper
• Neoadjuvant chemotherapy in locally advanced colon cancer: a systematic review

  2020cites this paper
• Predictive Factors of Positive Circumferential and Longitudinal Margins in Early T3 Colorectal Cancer Resection

  2020cites this paper
• How should colorectal surgeons practice during the COVID-19 epidemic? A retrospective single-center analysis based on real-world data from China.

  2020cites this paper
• Colon sparing resection versus extended colectomy for left‐sided obstructing colon cancer with caecal ischaemia or perforation: a nationwide study from the French Surgical Association

  2020cites this paper
• Correlation between UGT1A1 gene polymorphism and irinotecan chemotherapy in metastatic colorectal cancer: a study from Guangxi Zhuang

  2020cites this paper
• The impact of mismatch repair status to the preoperative staging of colon cancer: implications for clinical management

  2020cites this paper
• Accuracy of preoperative staging with multidetector computed tomography in colon cancer

  2020cites this paper
• Early stage colon cancer: Current treatment standards, evolving paradigms, and future directions

  2020cites this paper
• Is Adjuvant Chemotherapy Necessary for Obstructing Stage II Colon Cancer? Results From a Propensity Score Analysis of the French Surgical Association Database

  2020cites this paper
• Reporting colon cancer staging using a template

  2020cites this paper
• Selektionskriterien zur neoadjuvanten Radiochemotherapie beim Rektumkarzinom

  2020cites this paper
• Targeted next generation sequencing validates the use of diagnostic biopsies as a suitable alternative to resection material for mutation screening in

  2020cites this paper
• Colon Cancer: Time for MRI has come?

  2019cites this paper
• Neoadjuvant Treatment for Locally Advanced Colon Cancer

  2019cites this paper
• Colon Cancer Staging: When Does High Resolution MRI Have a Role?

  2019cites this paper
• Performance comparison between MRI and CT for local staging of sigmoid and descending colon cancer.

  2019cites this paper
• Potential image-based criteria of neoadjuvant chemotherapy for colon cancer: multireaders’ diagnostic performance

  2019cites this paper
• MicroRNA-126 and epidermal growth factor-like domain 7 predict recurrence in patients with colon cancer treated with neoadjuvant chemotherapy

  2019cites this paper
• Accuracy of CT colonography in the preoperative staging of colon cancer: a prospective study of 217 patients

  2019cites this paper
• Clinical Evaluation of Preoperative Radiotherapy Combined with FOLFOX Chemotherapy on Patients with Locally Advanced Colon Cancer

  2019cites this paper
• Efficacy of Neoadjuvant Chemotherapy with Capecitabine plus Oxaliplatin in the Treatment of Locally Advanced Sigmoid Colon Cancer Invading the Urinary Bladder: A Report of Three Cases

  2019cites this paper
• Refining adjuvant therapy for non-metastatic colon cancer, new standards and perspectives.

  2019cites this paper
• CapeOX perioperative chemotherapy versus postoperative chemotherapy for locally advanced resectable colon cancer: protocol for a two-period randomised controlled phase III trial

  2019cites this paper
• Targeted Next-Generation Sequencing Validates the Use of Diagnostic Biopsies as a Suitable Alternative to Resection Material for Mutation Screening in Colorectal Cancer

  2019cites this paper
• Neoadjuvant radiation for clinical T4 colon cancer: A potential improvement to overall survival☆,☆☆

  2019cites this paper
• Serial mutational tracking in surgically resected locally advanced colorectal cancer with neoadjuvant chemotherapy

  2018cites this paper
• Neoadjuvant chemoradiotherapy followed by surgery in patients with unresectable locally advanced colon cancer: a prospective observational study

  2018cites this paper
• Correlation Between Clinical and Pathologic Staging in Colon Cancer: Implications for Neoadjuvant Treatment

  2018cites this paper
• neoadjuvant chemoradiotherapy followed by surgery in patients with unresectable locally advanced colon cancer: a prospective observational study

  2018cites this paper
• Neoadjuvant Radiation Therapy in Locally Advanced Colon Cancer: a Cohort Analysis

  2018cites this paper
• La chimiothérapie néoadjuvante dans le cancer du côlon non métastatique

  2018cites this paper
• Mid-term oncologic outcome of a novel approach for locally advanced colon cancer with neoadjuvant chemotherapy and surgery

  2017cites this paper
• Need for adjuvant chemotherapy after colon cancer surgery – has it decreased?

  2017cites this paper